Iradimed Dividends
| IRMD Stock | USD 42.03 0.47 1.11% |
At present, Iradimed's Dividend Payout Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 2.71, whereas Dividends Paid is projected to grow to (12.6 M). Iradimed's past performance could be the main factor of why investors trade Iradimed Co stock today. Investors should clearly understand every aspect of the Iradimed dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Iradimed's dividend schedule and payout information. Iradimed Co dividends can also provide a clue to the current valuation of Iradimed.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -13.2 M | -12.6 M | |
| Dividend Yield | 0.02 | 0.03 | |
| Dividend Payout Ratio | 0.77 | 0.96 | |
| Dividend Paid And Capex Coverage Ratio | 2.58 | 2.71 |
Iradimed |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Iradimed must own a stock before its ex-dividend date to receive its next dividend.
Iradimed Dividends Paid Over Time
Today, most investors in Iradimed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Iradimed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Iradimed dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Iradimed Historical Dividend Yield Growth
A solid dividend growth pattern of Iradimed could indicate future dividend growth is likely, which can signal long-term profitability for Iradimed Co. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Iradimed Co dividend as a percentage of Iradimed stock price. Iradimed dividend yield is a measure of Iradimed stock productivity, which can be interpreted as interest rate earned on an Iradimed investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Iradimed Expected Dividend Income Per Share
Dividend payment represents part of Iradimed's profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Iradimed. Iradimed's board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.39 Bottom Scenario | $0.4 | $0.41 Top Scenario |
One Year
Iradimed Co expected dividend income per share adjusted for ongoing price standard deviation
Iradimed Past Distributions to stockholders
A dividend is the distribution of a portion of Iradimed earnings, decided and managed by the Iradimeds board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Iradimed dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.
Is Iradimed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.185 | Dividend Share 0.15 | Earnings Share 1.4 | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.137 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.